sodium alkylsulfoacetate + sodium citrate: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
sodium alkylsulfoacetate + sodium citrate: clinical details
Prescribing considerations
- Assess persistent symptoms, abdominal pain, rectal bleeding, weight loss or an abrupt bowel-habit change before repeated treatment.
- Avoid prolonged or excessive use; excessive use can cause diarrhoea and fluid loss.
Contraindications and cautions
- Inflammatory bowel disease.
- Hypersensitivity to either active ingredient or an excipient.
Monitoring
- Assess clinical response and investigate constipation that worsens, persists or repeatedly requires rectal treatment.
- Assess hydration if substantial diarrhoea occurs.
Clinical pharmacology
A locally acting rectal formulation: sodium citrate displaces water bound in faeces, sorbitol enhances this action, and sodium alkylsulfoacetate acts as a wetting agent. Pharmacokinetic data are not specified.
Formulation and product differences
- Rectal emulsion in a single-use polyethylene micro-enema tube with an elongated nozzle.
- Excipients include liquid sorbitol, glycerin, sorbic acid and purified water.
sodium alkylsulfoacetate + sodium citrate interactions
No medicine interactions are listed in the selected product information. Tell a pharmacist or prescriber about other rectal products or laxatives, particularly if symptoms continue or diarrhoea develops.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.